Increased stability of microtubules in cultured olfactory neuroepithelial cells from individuals with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 48, Issue , 2014, Pages 252-258

  Brown, Alan S ^a,b   Borgmann Winter, Karin ^c   Hahn, Chang Gyu ^c   Role, Lorna ^d   Talmage, David ^e   Gur, Raquel ^f   Chow, Jacky ^a   Prado, Patric ^b   McCloskey, Thelma ^c   Bao, Yuanyuan ^a   Bulinski, J Chloe ^g   Dwork, Andrew J ^a,h,i  

^a New York State Psychiatric Institute ^*  (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Stony Brook University   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g Macedonian Academy of Sciences and Arts ^*  (United States)

^h Department of Medicine   (United States)

ⁱ MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

Author keywords

Microtubules; Olfactory; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BETA TUBULIN; NOCODAZOLE;

ADULT; AGE; ARTICLE; CELL COUNT; CELL FUNCTION; CELL GROWTH; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLYMERIZATION; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; MICROTUBULE; NEUROBIOLOGY; NEUROBLAST; NEUROEPITHELIUM; OLFACTORY EPITHELIUM; PATHOPHYSIOLOGY; SCHIZOPHRENIA;

EID: 84887363586     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.10.015     Document Type: Article

References (73)

1. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996, 53:425-436.
2. Anderson S.A., Volk D.W., Lewis D.A. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 1996, 19:111-119.
3. Andrieux A., Salin P.A., Vernet M., Kujala P., Baratier J., Gory-Faure S., et al. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev 2002, 16:2350-2364.
4. Andrieux A., Salin P., Schweitzer A., Begou M., Pachoud B., Brun P., et al. Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol Psychiatry 2006, 60:1224-1230.
5. Arnold S.E., Lee V.M., Gur R.E., Trojanowski J.Q. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 1991, 88:10850-10854.
6. Balu D.T., Coyle J.T. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev 2011, 35:848-870.
7. Beasley C.L., Cotter D.R., Everall I.P. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Mol Psychiatry 2002, 7:564-570.
8. Benitez-King G., Ramirez-Rodriguez G., Ortiz L., Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr Drug Targets CNS Neurol Disord 2004, 3:515-533.
9. Benitez-King G., Riquelme A., Ortiz-Lopez L., Berlanga C., Rodriguez-Verdugo M.S., Romo F., et al. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases. J Neurosci Methods 2011, 201:35-45.
10. Brun P., Begou M., Andrieux A., Mouly-Badina L., Clerget M., Schweitzer A., et al. Dopaminergic transmission in STOP null mice. J Neurochem 2005, 94:63-73.
11. Buchsbaum M.S., Schoeknect P., Torosjan Y., Newmark R., Chu K.W., Mitelman S., et al. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann Gen Psychiatry 2006, 5:19.
12. Buck K.B., Zheng J.Q. Growth cone turning induced by direct local modification of microtubule dynamics. J Neurosci 2002, 22:9358-9367.
13. Bulinski J.C., Gundersen G.G. Stabilization of post-translational modification of microtubules during cellular morphogenesis. Bioessays 1991, 13:285-293.
14. Connor C.M., Crawford B.C., Akbarian S. White matter neuron alterations in schizophrenia and related disorders. Int J Dev Neurosci 2011, 29:325-334.
15. Cotter D., Wilson S., Roberts E., Kerwin R., Everall I.P. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 2000, 41:313-323.
16. Curley A.A., Arion D., Volk D.W., Asafu-Adjei J.K., Sampson A.R., Fish K.N., et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry 2011, 168:921-929.
17. Dent E.W., Gertler F.B. Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron 2003, 40:209-227.
18. Dent E.W., Gupton S.L., Gertler F.B. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb Perspect Biol 2011, 3:a001800.
19. Dresner E., Agam G., Gozes I. Activity-dependent neuroprotective protein (ADNP) expression levels is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia. Eur Neuropsychopharmacol 2011, 21:355-361.
20. Dwork A.J., Mancevski B., Rosoklija G. White matter and cognitive function in schizophrenia. Int J Neuropsychopharmacol 2007, 10:513-536.
21. Eastwood S.L., Harrison P.J. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 2003, 769:821-831.
22. Eastwood S.L., Harrison P.J. Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia. Schizophr Res 2005, 79:181-188.
23. Falkai P., Schneider-Axmann T., Honer W.G. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of development abnormality. Biol Psychiatry 2000, 47:937-943.
24. Fradley R.L., O'Meara G.F., Newman R.J., Andrieux A., Job D., Reynolds D.S. STOP knockouts and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 2005, 63:257-264.
25. Fung S.J., Webster M.J., Sivagnanasundaram S., Duncan C., Elashoff M., Weickert C.S. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry 2010, 167:1479-1488.
26. Fung S.J., Joshi D., Allen K.M., Sivagnanasundaram S., Rothmond D.A., Saunders R., et al. Developmental patterns of doublecortin expression and white matter neuron density in the postnatal primate prefrontal cortex and schizophrenia. PLoS One 2011, 6:e25194.
27. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998, 65:446-453.
28. Geraldo S., Gordon-Weeks P.R. Cytoskeletal dynamics in growth-cone steering. J Cell Sci 2009, 122:3595-3604.
29. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57:65-73.
30. Greer P.L., Greenberg M.E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 2008, 59:846-860.
31. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000, 57:1061-1069.
32. Gundersen G.G., Bulinski J.C. Selective stabilization of microtubules oriented toward the direction of cell migration. Proc Natl Acad Sci U S A 1988, 85:5946-5950.
33. Hahn C.G., Han L.Y., Rawson N.E., Mirza N., Borgmann-Winter K., Lenox R.H., et al. In vivo and in vitro neurogenesis in human olfactory epithelium. J Comp Neurol 2005, 483:154-163.
34. Hoogenraad C.C., Akhmanova A. Dendritic spine plasticity: new regulatory roles of dynamic microtubules. Neuroscientist 2010, 16:650-661.
35. Jarskog L.F., Dong Z., Kangarlu A., Colibazzi T., Girgis R.R., Kegeles L.S., et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology 2013, 38:1245-1252.
36. Javitt D.C., Buchanan R.W., Keefe R.S., Kern R., McMahon R.P., Green M.F., et al. Effects of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res 2012, 136:25-31.
37. Jaworski J., Hoogenraad C.C., Akhmanova A. Microtubule plus-end tracking proteins in differentiated mammalian cells. Int J Biochem Cell Biol 2008, 40:619-637.
38. Jaworski J., Kapitein L.C., Gouveia S.M., Dortland B.R., Wulf P.S., Grigoriev I., et al. Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009, 61:85-100.
39. Joshi D., Fung S.J., Rothwell A., Weickert C.S. Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry 2012, 72:725-733.
40. Kalus P., Muller T.J., Zuschratter W., Senitz D. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 2000, 11:3621-3625.
41. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005, 7:1167-1178.
42. Keshavan M.S., Tandon R., Boutros N.N., Nasrallah H.A. Schizophrenia, "just the facts": what we know in 2008 part 3: neurobiology. Schizophr Res 2008, 106:89-107.
43. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 2012, 35:57-67.
44. Liu N., Shields C.B., Roisen F.J. Primary culture of adult mouse olfactory receptor neurons. Exp Neurol 1998, 151:173-183.
45. Lowry L.D., Pribitkin E.A. Collection of human olfactory tissue. Experimental biology of taste and olfaction 1995, 47-48. CRC Press, Boca Raton, FL. A.I. Spielman, J.G. Brand (Eds.).
46. Marenco S., Stein J.L., Savostyanova A.A., Sambataro F., Tan H.Y., Goldman A.L., et al. Investigation of anatomical thalamo-cortical connectivity and fMRI activation in schizophrenia. Neuropsychopharmacology 2012, 37:499-507.
47. Martins-de-Souza D., Gattaz W.F., Schmitt A., Maccarrone G., Hunyadi-Gulyas E., Eberlin M.N., et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 2009, 43:978-986.
48. Merenlender-Wagner A., Pikman R., Giladi E., Andrieux A., Gozes I. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse-a microtubule-deficient model of schizophrenia. Peptides 2010, 31:1368-1373.
49. Merriam E.B., Lumbard D.C., Viesselmann C., Ballweg J., Stevenson M., Pietila L., et al. Dynamic microtubules promote synaptic NMDA receptor-dependent spine enlargement. PLoS One 2011, 6:e27688.
50. Morris J.A., Kandpal G., Ma L., Austin C.P. DISC1 (disrupted-in-schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 2003, 12:1591-1608.
51. Mukaetova-Ladinska E., Hurt J., Honer W.G., Harrington C.R., Wischik C.M. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett 2002, 317:161-165.
52. Oz S., Ivashko-Pachina Y., Gozes I. The ADNP derived peptide, NAP modulates the tubulin pool: implications for neurotropic and neuroprotective activities. PLoS One 2012, 7:e51458.
53. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:51-59.
54. Perez F., Diamantopoulos G.S., Stalder R., Kreis T.E. CLIP-170 highlights growing microtubule ends in vivo. Cell 1999, 96:517-527.
55. Piperno G., LeDizet M., Chang X.J. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 1987, 104:289-302.
56. Rioux L., Nissanov J., Lauber K., Bilker W.B., Arnold S.E. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am J Psychiatry 2003, 160:149-155.
57. Rioux L., Ruscheinsky D., Arnold S.E. Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia. Psychiatry Res 2004, 128:1-7.
58. Rodriguez O.C., Schaefer A.W., Mandato C.A., Forscher P., Bement W.M., Waterman-Storer C.M. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 2003, 5:599-609.
59. Rosoklija G., Toomayan G., Ellis S.P., Kelip J., Mann J.J., Latov N., et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000, 57:349-356.
60. Sabry J.H., O'Connor T.P., Evans L., Toroian-Raymond A., Kirschner M., Bentley D. Microtubule behavior during guidance of pioneer neuron growth in cones in situ. J Cell Biol 1991, 115:381-395.
61. Shimizu H., Iwayama Y., Yamada K., Toyota T., Minabe Y., Nakamura K., et al. Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res 2006, 84:244-252.
62. Solis-Chagoyan H., Calixto E., Figueroa A., Montano L.M., Berlanga C., Rodriguez-Verdugo M.S., et al. Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder. Schizophr Res 2013, 143:384-389.
63. Somenarain L., Jones L.B. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea. J Psychiatr Res 2010, 44:694-699.
64. Straub R.E., Lipska B.K., Egan M.F., Goldberg T.E., Callicott J.H., Mayhew M.B., et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007, 12:854-869.
65. Tanaka E., Kirschner M.W. The role of microtubules in growth cone turning at substrate boundaries. J Cell Biol 1995, 128:127-137.
66. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 2009, 110:1-23.
67. van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008, 34:1066-1082.
68. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000, 57:237-245.
69. Wang Q., Su T.P., Zhou Y., Cou K.H., Chen I.Y., Jiang T., et al. Anatomical insights into disrupted small-world networks in schizophrenia. Neuroimage 2012, 59:1085-1093.
70. Wayman G.A., Lee Y.S., Tokumitsu H., Silva A., Soderling T.R. Calmodulin-kinase: modulators of neuronal development and plasticity. Neuron 2008, 59:914-931.
71. Whitford T.J., Savadjiev P., Kubicki M., O'Donnell L.J., Terry D.P., Bouix S., et al. Fiber geometry in the corpus callosum in schizophrenia: evidence for transcallosal misconnection. Schizophr Res 2011, 132:69-74.
72. Yang Y., Fung S.J., Rothwell A., Tianmei S., Weickert C.S. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 2011, 69:63-70.
73. Zalesky A., Fornito A., Seal M.L., Cocchi L., Westin C.F., Bullmore E.T., et al. Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry 2011, 69:80-89.